TY - JOUR
T1 - MicroRNA signatures of colonic polyps on screening and histology
AU - Tsikitis, Vassiliki L.
AU - Potter, Amiee
AU - Mori, Motomi
AU - Buckmeier, Julie A.
AU - Preece, Christina R.
AU - Harrington, Christina A.
AU - Bartley, Angela N.
AU - Bhattacharyya, Achyut K.
AU - Hamilton, Stanley R.
AU - Lance, M. Peter
AU - Thompson, Patricia A.
N1 - Publisher Copyright:
© 2016 American Association for Cancer Research.
PY - 2016/12
Y1 - 2016/12
N2 - Colorectal cancer and adenoma adjacent to cancer exhibit distinct microRNA (miRNA) alterations in an apparent mucosato-adenocarcinoma sequence. The pattern of microRNAs in screen-detected polyps in relation to histologic features and cancer risk has not been investigated. miRNA expression analysis was performed on normal mucosa (NM), hyperplastic polyps (HP), tubular adenomas (TA), tubulovillous adenomas or high-grade dysplasia (TVHG), and serrated polyps [sessile serrated adenoma/polyps (SSA/P) and traditional serrated adenomas (TSA)] in biopsy specimens from 109 patients undergoing screening/surveillance colonoscopy. Generalized linear models were used to identify differentially expressed miRNAs by histologic type and logistic regression to identify miRNA predictors of histopathology. False discovery rate (FDR) was used to control for multiple comparisons. We identified 99 miRNAs differing in at least one of five histopathologic groups (FDR ≤0.05). In a comparison of HPNM versus TVHG, the top most upregulated and downregulated miRNAs in HPNM included miR-145,-143,-107,-194, and-26a (upregulated), and miR-663,-1268,-320b,-1275, and-320b (downregulated; FDR P 0.05). miR-145 and-619 showed high accuracy to discriminate low-from highrisk polyps without serrated histology (TVHG vs. HPNM \+ TA; CI, 95.6%), whereas miR-124,-143, and-30a showed high accuracy of separating high-risk polyps (TVHG \+ TSA) from low-risk polyps (HPNM \+ TA \+ SSA/P; CI, 96.0%). For TSAs, miR-125b and-199a were uniquely downregulated relative to HPNMs, and miR-335,-222, and-214 discriminated between non-serrated and serrated histology. Our data support the presence of colorectal cancer-associated miRNA alterations in screen-detected adenomas that may be useful for risk stratification for surveillance interval planning.
AB - Colorectal cancer and adenoma adjacent to cancer exhibit distinct microRNA (miRNA) alterations in an apparent mucosato-adenocarcinoma sequence. The pattern of microRNAs in screen-detected polyps in relation to histologic features and cancer risk has not been investigated. miRNA expression analysis was performed on normal mucosa (NM), hyperplastic polyps (HP), tubular adenomas (TA), tubulovillous adenomas or high-grade dysplasia (TVHG), and serrated polyps [sessile serrated adenoma/polyps (SSA/P) and traditional serrated adenomas (TSA)] in biopsy specimens from 109 patients undergoing screening/surveillance colonoscopy. Generalized linear models were used to identify differentially expressed miRNAs by histologic type and logistic regression to identify miRNA predictors of histopathology. False discovery rate (FDR) was used to control for multiple comparisons. We identified 99 miRNAs differing in at least one of five histopathologic groups (FDR ≤0.05). In a comparison of HPNM versus TVHG, the top most upregulated and downregulated miRNAs in HPNM included miR-145,-143,-107,-194, and-26a (upregulated), and miR-663,-1268,-320b,-1275, and-320b (downregulated; FDR P 0.05). miR-145 and-619 showed high accuracy to discriminate low-from highrisk polyps without serrated histology (TVHG vs. HPNM \+ TA; CI, 95.6%), whereas miR-124,-143, and-30a showed high accuracy of separating high-risk polyps (TVHG \+ TSA) from low-risk polyps (HPNM \+ TA \+ SSA/P; CI, 96.0%). For TSAs, miR-125b and-199a were uniquely downregulated relative to HPNMs, and miR-335,-222, and-214 discriminated between non-serrated and serrated histology. Our data support the presence of colorectal cancer-associated miRNA alterations in screen-detected adenomas that may be useful for risk stratification for surveillance interval planning.
UR - http://www.scopus.com/inward/record.url?scp=85008323066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008323066&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-16-0086
DO - 10.1158/1940-6207.CAPR-16-0086
M3 - Article
C2 - 27658891
AN - SCOPUS:85008323066
SN - 1940-6207
VL - 9
SP - 942
EP - 949
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 12
ER -